SMi Group Ltd.

SMi’s inaugural Diabetes, Cardiovascular & Renal Complications conference will be held on 28th & 29th November in London is the perfect forum to assess the changing spectrum of therapies in development for treating diabetes.

SMi’s 7th annual Cold Chain Distribution conference will take place on the 3rd & 4th December London is Europe’s leading event and will provide attendees the chance to network with industry professionals at the forefront of innovation.

This conference will allow for key leaders in social media, communications, e-marketing and market research, to meet and discuss the innovations in social media, and the ways to approach each new and emerging field.

COPD: Novel Therapeutics & Management Strategies conference held on the 22nd & 23rd October in London will address therapeutic and management strategies for COPD with an international mix of key opinion leaders in this ever expanding field.

SMi’s 18th annual European Pharmaceutical Pricing and Reimbursement conference taking place on 29th & 30th October 2012 in London, UK

This conference will address the latest developments and procedures used in the identification and prevention of contaminating agents; the design and validation of new lab environments; sterile manufacture and process validation.

Drawing on advances in genomics, translational medicine and clinical trial design, SMi’s sixth annual Biomarkers Summit held on 16th &17th January 2013 London brings you the latest developments in this field.

SMi inaugural Diabetes, Cardiovascular & Renal Complications conference held on the 28th & 29th November in London will join senior executives from leading companies at the only conference dedicated to the leading causes of morbidity in diabetes.

This event will bring together the biggest players in this fast-paced field and will provide a unique forum for discussion and debate into the key issues in COPD therapeutics and management strategies.

This event will discuss the latest developments in preclinical discover, clinical trial design, clinical trial management and the latest developments in neurodegenerative treatments and will feature talks from top pharmaceutical companies.